# Cancer Center Support Grant

> **NIH NIH P30** · UNIVERSITY OF MINNESOTA · 2022 · $60,419

## Abstract

COVID-19 vaccination substantially reduces morbidity and mortality associated with SARSCoV-2 infection and severe illness. However, despite the availability of effective COVID-19 vaccines, many questions remain about the efficacy of these vaccines and the durability and robustness of immune responses, especially in immunocompromised persons. We propose a single two-year data pooling project that merges data from both (i) electronic medical records, as well as (ii) prospective vaccine response study cohorts from 11 Serological Sciences Network (SeroNet) sites across the U.S. The coordinated effort of multiple SeroNet sites is crucial for generating results more generalizable to the wider U.S. population, including investigation of sources of vaccine response heterogeneity (e.g., age, sex, race/ethnicity and geography).

## Key facts

- **NIH application ID:** 10703639
- **Project number:** 3P30CA077598-24S2
- **Recipient organization:** UNIVERSITY OF MINNESOTA
- **Principal Investigator:** Douglas Yee
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $60,419
- **Award type:** 3
- **Project period:** 1998-06-01 → 2024-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703639

## Citation

> US National Institutes of Health, RePORTER application 10703639, Cancer Center Support Grant (3P30CA077598-24S2). Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/grant/nih/10703639. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*